Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina
A chimeric Mela(CTmGluR6) optogenetic tool has the potential to restore vision and signaling in a mouse model of degenerative retinal disease.
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-04016-1 |